mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.02 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |